|
Video: What is a Stock Split?
|
|
Syneos Health is a holding company. Through its subsidiaries, Co. is an integrated biopharmaceutical solutions organization. Co.'s segments are: Clinical Solutions, which provides services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, and clinical monitoring; and Commercial Solutions, which provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services. According to our SYNH split history records, SYNH has had 0 splits. | |
|
SYNH (SYNH) has 0 splits in our SYNH split history database.
Looking at the SYNH split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SYNH shares, starting with a $10,000 purchase of SYNH, presented on a split-history-adjusted basis factoring in the complete SYNH split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/10/2014 |
|
End date: |
09/28/2023 |
|
Start price/share: |
$20.67 |
|
End price/share: |
$42.98 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
107.93% |
|
Average Annual Total Return: |
8.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$20,796.50 |
|
Years: |
8.88 |
|
|
|
|
|